health. To fully harness this potential and create a baseline of healthy stool protein 50 abundances and identifications, it will be important to establish the extent to which these 51 proteins might vary in the absence of disease. This study quantifies the major sources 52 of variation in stool protein abundance data. We assessed technical, preparative, 53 temporal, and inter-subject variability of human protein abundances in stool and found 54 3 that among these sources, differences between subjects accounted for the greatest 55 amount of variation, followed by temporal differences, and then technical factors. Our 56 paired microbiome analysis found matching patterns of temporal and inter-subject 
Introduction

62
The expression of host proteins in the human gastrointestinal tract contributes to the 63 health of that ecosystem, helping to regulate the diverse communities of microbes 64 whose composition and activities in turn affect host physiology. By understanding better 65 the identity of these proteins and their relative abundances we gain another window, 
79
Prior efforts to understand gastrointestinal health have focused on the gut microbiota.
80
Trillions of microbes living inside the human gastrointestinal tract exert a strong 81 influence on host health, both locally in the intestinal tract, and throughout the body.
82
Microbial community surveys using 16S rRNA sequence data can track perturbations 
100
We argue that establishing the parameters of a healthy gastrointestinal tract proteome 101 is an important prerequisite for identifying the stool proteins and their abundances that 102 might be capable of defining a wide range of health. Since human stool specimens are 103 inherently generated under uncontrolled, non-laboratory conditions, the ability to 104 extrapolate from studies of protein dynamics in laboratory animals is fundamentally 105 limited. We expect that the confluence of diet, exercise, and environmental stressors 106 cause stool protein abundances to vary significantly over time and between individuals.
107
This should affect their utility as reliable biomedical diagnostic tools.
108
Here, we compare stool proteins and microbial community compositions from five 109 subjects surveyed over eight time points spanning four weeks. We developed a 110 statistical approach that contends with the stochasticity inherent to these kinds of 111 shotgun proteomics studies, and that enabled three key findings. First, we found that 112 technical sources of measurement variation were largely insignificant (log(p) > -1.30), 113 an essential prerequisite for performing large-scale, clinical studies. Second, we 114 confirm that host-expressed stool proteins vary over time, but that variation between 115 subjects is far greater than this intra-host temporal variability. Third, by comparing 116 protein profiles to parallel microbial 16S rRNA gene sequence surveys, we found that 117 while they reveal comparable subject-specific profiles, the proteomic data provide 118 complementary insight into human inflammation. We designed a human stool sampling protocol that allowed us to assess measurement 124 variation over time and between subjects. We surveyed stool from five self-reported 125 healthy subjects over four weeks. Each subject provided one stool specimen on the 126 same two consecutive days of each week for four weeks, totaling eight specimens per 127 subject (Fig. 1A) inter-individual trends were measured in parallel using 16S rRNA V4-V5 amplicon 136 surveys without replication.
137
We measured 456 stool proteins across all subjects and time points (protein FDR 138 <1.5%; Fig. 2A ). Total unique protein identifications per subject ranged from 256 to 384.
139
Several prominent protein functional groups were enriched above the expected 140 presence in the entire human proteome among these proteins, including 141 immunoglobulins (4.3-fold), serine proteases (7.4-fold), and protease inhibitors (9.76-142 fold) (Fig. 2B) . These protein classes have clear gastrointestinal relevance, and support 143 our method's ability to enrich for proteins mediating interactions between the host, gut 144 microbes, and diet (8).
145
Our parallel 16S rRNA survey enumerated 1,770 microbial amplicon sequence variants
146
(ASVs) across all subjects and time points, with 320 to 808 unique ASVs identified per 147 subject (Supp. Fig. 1 ). ASVs were associated with nine bacterial and one archaeal 148 phyla, with Firmicutes (range 54%-79%, mean 70%) and Bacteroidetes (range 6%-31%, 149 mean 18%) dominating the gut microbiota of all subjects (Supp. Fig. 2 ). Actinobacteria (0.5%-3.5%), Proteobacteria (0.4%-1.2%) and Verrucomicrobia (0.05%-28%) were also 151 detected in all subjects. Euryarchaeota, the archaeal phylum containing methanogens, 152 was detected in two subjects (3.0% and 7.1%).
153
Phylum-level relative abundances have been reported to vary widely and are sensitive 154 to cell lysis procedures (11). Nevertheless, our results are consistent with the ranges 155 reported previously for healthy adults (12, 13). At a finer scale, both the microbial 156 families and species we detected, and their variability over time within subjects, are 157 similar to published results from healthy adults ( Supp Fig 3) (14, 15 3A ).
168
Non-parametric significance testing can be achieved with a logistic regression to 169 determine whether a given protein was consistently identified (i.e., presence/absence).
170
ANOVA provides comparable statistical rigor for evaluating how consistent protein 171 abundance measurements are. However, both tests require that the number of proteins 172 to be considered are less than the overall number of observations (i.e., N<160). We 173 therefore selected a small subset of frequently identified proteins which were shared 174 among all five subjects, and which would meet the ANOVA criteria. To meet these 175 constraints we partitioned our protein identifications in three ways ( Fig. 2C) quantified (significantly variable given that it was identified) (Fig 3A) . (Fig. 1B) (Fig 3B) . 201 We expected preparative variation to be greater than technical variation due to the (Supp Fig 4) Prior analyses of human stool proteins gave limited consideration to longitudinal 215 variation in the absence of a perturbation (8, 10, 17) . Accordingly, the extent to which 216 stool proteins vary in healthy adults over time within subjects is unclear. Our 217 experimental design (Fig. 1A) reported by Tropini et al (18) .
227
In contrast, we expect proteins that are induced by inflammation to be consistently 228 expressed over time within healthy subjects. Accordingly, we found that the 229 identification and abundances measured for the neutrophil-expressed inflammation 230 marker, calprotectin (S100A9) did not vary significantly over time (log(p) > -1.30 by both 231 identification and abundance tests). Two other known markers of gastrointestinal 232 inflammation within our shared protein subset were consistently identified and quantified 233 over time in our assay: DMBT1, which was shown to be upregulated in Crohn's disease 234 (19), along with S100A8, another fecal calprotectin subunit (Fig. 3D) . However, there 235 were many more clinical biomarkers in our gastrointestinal proteome that were excluded 236 due to their lack of shared presence or high abundance or entropy amongst subjects.
237
Current clinical biomarkers include S100A12, lactoferrin, metalloproteinases, 238 myeloperoxidases, and neutrophil elastase, all of which we observed in our full dataset. The temporal variances we observed across the shared protein subset (Fig. 3D) profiles did not demonstrate any obvious progression over time in any subject (Fig 4C) . 252 Furthermore, we found that the summed Euclidean distances between each point also 253 ranged substantially across each individual. This temporal sampling helps to establish a 254 range above which a researcher could describe as a perturbation.
255
Noting that eight proteins accounted for almost 50% of total protein abundance across 256 all specimens and replicates, we wondered if any could have had a disproportionate 257 influence on our temporal measurements. Accordingly, we compared how these protein measured from subject 2 (e.g., a max 3.4 fold change between any two days) but were 265 fairly consistent in subject 4 (at most a 1.6-fold change between any two days) (Supp inter-subject log(p) = -22.65 for protein AMPN). Calprotectin subunit S100A9's 295 abundance variability was exemplary of this larger inter-subject variation trend (inter-296 subject log(p) = -6.30, temporal log(p) = -0.92) (Supp. Fig. 4 ). While fecal calprotectin
297
(heterodimer of S100A9 and S100A8) levels are used to distinguish between healthy 298 and inflamed guts, our experiment suggests that S100A9, despite little temporal 299 variability within subject, has a large intrinsic abundance variability between healthy 300 subjects (quantification log(p) = -6.30 identification log(p) > -1.30) and S100A8 was considering all of the proteins we reported in Figure 2 and not just the shared protein 311 subset ( See Fig legend 4A ). We observed strong, though not complete, inter-subject 312 grouping ( Fig 4A) . We used Bray-Curtis dissimilarity to be consistent across both 313 proteome and microbiome data types, but Euclidean distance is often applied to protein 314 data sets as a measure of specimen dissimilarity (which, unlike Bray-Curtis, considers 315 the shared absence of a protein in specimens as evidence of their similarity) (Supp Fig   316   6 ). The Euclidean distance separated subjects with a similar distinction to the Bray 317 Curtis separation.
318
Subject 4 was the most distinct individual, using the Bray Curtis distance (Fig. 4A) .
319
Several proteins were upregulated in this individual relative to the others, including 320 CUB/zona pellucida-like domain-containing protein (CUZD1), pancreatic zymogen 321 molecule 2 (GP2) (Supp. Fig. 7 ). Both of these proteins are targets of pancreatic 322 autoantibodies and GP2 is upregulated in Crohn's disease patients (22).
323
It would be useful to identify a set of proteins, which are commonly found in healthy was between subjects (p<0.0001) (Fig 4B, Supp Fig 8) . Subjects appeared equally 339 distinct from one another, with respect to their microbiota and their stool proteins when 340 comparing PCAs (Fig 4A,4B ). This might be surprising given that the human gut 341 microbiota is comprised of many independent species, while stool proteins are derived in subject 4) (Fig. 4B) , but showed high variance among host stool proteins (Fig. 4A) .
352
Additionally, other subjects were inconsistently distinguished by proteome and 353 microbiome data sets: proteins from subject 2 partially overlapped with those from 354 subject 3, but the gut microbiota completely separated these individuals.
355
Using PCA coordinates, we extracted both temporal patterns and Euclidean distances 356 between days and subsequently summed these temporal distances (Fig 4C) alongside 357 temporal microbial family changes ( Supp Fig 3) and, as we observed with the proteins, subject-specific temporal microbial shifts.
365
Temporal patterns were also quite dissimilar between protein and microbial data sets 366 (Fig 4C) . For example, the day 15 and 22 specimens from subjects 3 and 4 were quite 367 distinct from other days, as assessed from the microbiota. However, these particular 368 days were quite typical of the subject as assessed from their stool proteins. We found 369 that proteins and microbes exhibited little coordination over the duration of a month.
370
Furthermore, we note that the ordinations plotted here depended greatly on the choice 371 of distance/dissimilarity metric. We used Bray-Curtis dissimilarity to be consistent 372 across both data types, however microbiome researchers often compare specimens 373 using methods that account for the phylogenetic relatedness of microbial taxa (e.g.,
374
weighted Unifrac), unlike Bray-Curtis. Ordinations using these metrics were rather 375 different from Bray-Curtis (Supp Fig 6) . However, they did not suggest any consistent 376 inter-subject variability patterns shared between stool proteins and the gut microbiota 377 (Supp Fig 6) . We conclude that microbe and proteome-focused assays capture 378
related, yet distinct aspects of the dynamic gut ecosystem. Fig 7) . We therefore considered whether any subjects in our 384 study could be distinguished by the presence of other known inflammation-associated 385 proteins, and whether proteins with other functional annotations mirrored these 386 inflammation-related patterns. We selected proteins enriched in subject 2, but sparse in 387 all other subjects and found that they were enriched in proteins known to be associated Fig 9) .
390
To this answer this issue further, we selected quantification data for known fecal clinical 391 biomarkers from the entire dataset. This set included lactotransferrin, calprotectin 392 S100A9 and S100A8, neutrophil elastase, and myeloperoxidase (27). With the 393 exception of S100A9, these proteins were significantly more abundant in subject 2 394 compared to most subjects (Fig 5) The subset plot ("UpSetR" version 1.3.3) shows the proteins shared between each 442 subject. 174 proteins were identified from at least one time point across all subjects
443
(orange bar). 11% of the data set (52 proteins) were identified in just one subject. B.
444
The shared protein subset is the union between the 174 shared proteins, the top 20% CEL3A both had only inter-subject variability, and CTRB1 had only temporal variability. considers abundance but not phylogeny), indicating that abundant taxa tend to be more 548 closely related across subjects than is true for the microbiota as a whole. The 549 dissimilarity of a single specimen from others within subjects 4 and 5 primarily involves 550 changes in the relative abundance of taxa, not their identity. inter-subject specimens. Euclidean distances between all coordinates were obtained 562 from the PCA coordinates in Fig 4A,B. A Specimens from the protein PCA (Fig 4A) are 563 more similar within a single subject (intra-subject) than between subjects (inter-subject)
564
(p<0.0001, Mann-Whitney U). B Specimens from the microbe PCA (Fig 4B) are more 565 similar within a single subject (intra-subject) than between subjects (inter-subject)
566
(p<0.0001, Mann-Whitney U). from the resulting linear models with the "anova" function (package: stats version 3.5.1).
744
We considered the entire data matrix to calculate binary identification p values with a were then purified, pooled in equimolar concentrations, and sequenced on two 2 x 250
760
Illumina HiSeq paired-end runs.
761
After demultiplexing, raw reads were quality trimmed using the DADA2 pipeline (DADA2 transition from white to black. No trends were apparent from either data source.
793
Euclidean distances between each time point were summed to quantify the extent to 794 which subjects' specimens were temporally divergent. 
